Antimicrobial Resistance Testing in Animals: Methods, Standards, and Applications

Animal bacterial drug resistance testing, also known as veterinary antimicrobial susceptibility testing (AST), is a critical laboratory discipline that determines whether bacterial pathogens isolated from livestock, poultry, aquatic animals, and companion animals are susceptible or resistant to antimicrobial agents. As antimicrobial resistance (AMR) poses an escalating threat to animal health, food safety, and public health under the One Health framework, accurate resistance testing has become essential for guiding veterinary therapy, supporting national surveillance programs, and ensuring regulatory compliance. This article provides a comprehensive technical overview of sample types, target bacteria, testing methods, international standards, and practical applications of animal bacterial drug resistance testing.

Technical Overview

Antimicrobial resistance (AMR) in animal-associated bacteria is recognized by the World Health Organization (WHO) and the World Organisation for Animal Health (WOAH) as one of the most significant global threats to food security, veterinary medicine, and public health. Food-producing animals constitute a major reservoir of resistant bacteria and resistance genes, which can be transmitted to humans through the food chain, direct animal contact, and environmental pathways such as manure application and farm runoff. Consequently, systematic and standardized resistance testing of animal bacterial isolates is indispensable for rational antimicrobial use, early warning of emerging resistance, and cross-border trade compliance.

Animal bacterial drug resistance testing encompasses two complementary analytical approaches. Phenotypic methods measure the growth response of a bacterial isolate in the presence of defined concentrations of antimicrobial agents, producing quantitative endpoints such as the minimum inhibitory concentration (MIC) or qualitative zone-of-inhibition diameters. Genotypic methods detect the specific resistance determinants themselves, including resistance genes and chromosomal point mutations, using amplification-based or sequencing-based techniques. Accredited third-party laboratories typically combine both approaches to deliver clinically interpretable and epidemiologically meaningful results.

Interpretation of test results relies on veterinary-specific clinical breakpoints published by the Clinical and Laboratory Standards Institute (CLSI) in the VET01S document, as well as human clinical breakpoints from CLSI M100 and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) for zoonotic pathogens. For surveillance purposes, epidemiological cutoff values (ECOFFs) are increasingly used to distinguish wild-type populations from isolates with acquired resistance, providing higher sensitivity for detecting emerging resistance trends.

Testing Samples

Clinical Samples from Livestock and Poultry

Clinical specimens from cattle, swine, sheep, goats, and poultry include feces and intestinal contents, blood, urine, milk from mastitis cases, nasal swabs, tracheal and bronchoalveolar lavage fluids, joint fluid, abscess pus, and genital tract swabs. Proper collection under aseptic conditions, refrigerated transport, and timely processing are prerequisites for valid isolation and susceptibility results.

Post-Mortem and Tissue Samples

For diagnostic investigations of deceased animals, tissue specimens such as lung, liver, spleen, kidney, lymph nodes, and lesion sites are collected during necropsy. Tissues are also sampled in slaughterhouses as part of harmonized AMR monitoring programs targeting commensal indicator bacteria, including caecal contents from pigs, broilers, and cattle.

Aquatic Animal Samples

For finfish, shrimp, and shellfish, samples include kidney, liver, spleen, gill, skin lesions, and whole larvae or juveniles. Water, sediment, and biofilm samples from aquaculture ponds and recirculating systems are frequently tested to characterize the environmental resistome and assess the risk of resistance dissemination in aquatic production systems.

Companion Animal Samples

Isolates from dogs, cats, and horses are submitted from skin and ear infections, urinary tract infections, respiratory infections, wound infections, and dental procedures. Companion animal testing is particularly important for monitoring methicillin-resistant Staphylococcus pseudintermedius (MRSP) and extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales with zoonotic potential.

Food and Environmental Samples

Retail meat, poultry carcass rinses, eggs, raw milk, and seafood are tested to trace resistant bacteria along the food chain. Environmental samples such as manure, slurry, farm effluent, bedding, feed, and dust provide insight into the persistence and transmission of resistance determinants between animal production environments and the surrounding ecosystem.

Pre-Isolated Bacterial Strains

Pure bacterial cultures isolated by veterinary clinics, research institutions, or national reference laboratories can be submitted directly for confirmatory identification and antimicrobial susceptibility testing, provided that strains are transported under appropriate biosafety and cold-chain conditions.

Testing Items

Animal bacterial drug resistance testing covers a defined panel of target microorganisms and antimicrobial agents selected according to the animal species, infection site, and surveillance objectives.

• Gram-negative pathogens and indicator bacteria: Escherichia coli, Salmonella enterica serovars, Campylobacter jejuni and Campylobacter coli, Enterococcus faecalis and Enterococcus faecium (Gram-positive indicator), Klebsiella pneumoniae, Proteus mirabilis, Pasteurella multocida, Actinobacillus pleuropneumoniae, Pseudomonas aeruginosa, Aeromonas spp., Vibrio spp., and Edwardsiella spp.
• Gram-positive pathogens: Staphylococcus aureus including livestock-associated MRSA, Staphylococcus pseudintermedius, Streptococcus suis, Streptococcus agalactiae, Trueperella pyogenes, and Enterococcus spp.
• Antimicrobial classes tested: beta-lactams (penicillins, potentiated aminopenicillins, cephalosporins including 3rd and 4th generation), carbapenems, aminoglycosides (gentamicin, amikacin, neomycin), tetracyclines (doxycycline, oxytetracycline), amphenicols (florfenicol, chloramphenicol), macrolides (erythromycin, tylosin, tulathromycin), lincosamides, fluoroquinolones (enrofloxacin, marbofloxacin, ciprofloxacin), sulfonamides and trimethoprim, polymyxins (colistin), pleuromutilins (tiamulin), and rifampicin.
• Key resistance phenotypes: methicillin resistance (MRSA/MRSP), ESBL- and AmpC-producing Enterobacteraae, carbapenemase-producing organisms, vancomycin-resistant enterococci (VRE), colistin-resistant Enterobacterales, and fluoroquinolone-resistant Campylobacter and Salmonella.
• Resistance gene targets: bla gene families (blaTEM, blaSHV, blaCTX-M, blaCMY, blaVIM, blaNDM, blaKPC, blaOXA-48), mecA and mecC, mcr-1 through mcr-10, vanA and vanB, tet and sul gene families, erm genes, qnr determinants, and gyrA and parC mutations associated with fluoroquinolone resistance.

Testing Methods

Broth Microdilution Method

Broth microdilution is the reference quantitative method for MIC determination, performed in custom or commercial microtiter plates containing twofold serial dilutions of antimicrobial agents in cation-adjusted Mueller-Hinton broth. The procedure follows CLSI VET01 and ISO 20776-1, with incubation conditions adjusted for fastidious organisms such as Campylobacter, which requires microaerophilic atmosphere and supplemented media. Results are interpreted as susceptible, intermediate, or resistant using veterinary clinical breakpoints.

Agar Disk Diffusion Method

The Kirby-Bauer disk diffusion method, standardized in CLSI VET03 and CLSI M02, involves applying antimicrobial-impregnated paper disks onto inoculated agar plates and measuring inhibition zone diameters after incubation. This method is cost-effective, flexible in agent selection, and widely used for routine screening of clinical isolates from animals.

Gradient Diffusion Method

Gradient diffusion strips carrying a continuous concentration gradient of an antimicrobial agent provide a convenient means of MIC determination on agar plates. This method is particularly useful for confirming borderline MIC values, testing single agents such as colistin alternatives, and validating unusual resistance phenotypes detected by screening methods.

Agar Dilution Method

Agar dilution incorporates defined antimicrobial concentrations directly into agar plates and remains a validated alternative for MIC determination, especially useful for testing large numbers of isolates in surveillance studies and for agents with poor stability in broth systems.

Molecular Detection Methods

Conventional PCR, multiplex PCR, and real-time quantitative PCR enable rapid and specific detection of resistance genes directly from isolates or enriched samples. Molecular assays are indispensable for confirming mecA-mediated methicillin resistance, distinguishing ESBL from AmpC phenotypes, and screening for transferable colistin resistance encoded by mcr genes. Whole-genome sequencing (WGS) provides a comprehensive resistome profile, links resistance determinants to mobile genetic elements and plasmids, and supports source attribution and phylogenetic analysis in outbreak investigations.

Quality Control and Interpretation

Every testing run includes reference quality control strains such as Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25922, and Pseudomonas aeruginosa ATCC 27853, with acceptance criteria verified against CLSI and EUCAST quality control tables. Zone diameter and MIC interpretive criteria are applied per CLSI VET01S, CLSI M100, or EUCAST documents, and epidemiological cutoff values are used when surveillance-grade discrimination of the wild-type population is required.

Testing Standards and References

Animal bacterial drug resistance testing is governed by a framework of international and national standards that ensure methodological harmonization and result comparability across laboratories.

• CLSI VET01 and VET01S: reference methods and veterinary clinical breakpoints for antimicrobial disk and dilution susceptibility testing of bacteria isolated from animals.
• CLSI M02, M07, and M100: standardized disk diffusion, dilution methods, and performance standards for susceptibility testing applicable to zoonotic isolates.
• ISO 20776-1 and ISO 20776-2: reference broth microdilution method and evaluation of susceptibility testing devices.
• ISO 7218 and the ISO 6887 series: general requirements and preparation of test samples for microbiological examination.
• EUCAST documents: clinical breakpoints and ECOFF definitions used in European surveillance contexts.
• GB national standards: Chinese national and sector standards specifying isolation, identification, and susceptibility testing procedures for veterinary pathogens and foodborne bacteria.
• WOAH (OIE) Terrestrial and Aquatic Animal Health Codes: harmonized monitoring and surveillance recommendations for antimicrobial resistance in animal production.
• Codex Alimentarius guidelines: risk analysis principles for foodborne AMR relevant to food-animal testing programs.

Applications

Antimicrobial resistance testing in animals serves a broad spectrum of clinical, regulatory, and scientific purposes across the animal health and food production sectors.

• Clinical veterinary medicine: selection of effective antimicrobial therapy based on confirmed susceptibility profiles, reducing treatment failure, shortening disease duration, and supporting antimicrobial stewardship programs in farms and veterinary clinics.
• National AMR surveillance: generation of harmonized resistance data for integrated surveillance reports that track resistance prevalence in food-producing animals and inform national action plans on antimicrobial resistance.
• Food safety and trade compliance: verification of compliance with microbiological criteria and veterinary drug regulations in export consignments of meat, poultry, dairy, eggs, and aquatic products, supporting international market access.
• Farm health management: identification of herd- or flock-level resistance patterns to guide vaccination strategies, biosecurity improvements, and rotation of antimicrobial treatment protocols in livestock and poultry operations.
• Aquaculture: monitoring of resistance in fish and shrimp pathogens to support responsible antimicrobial use in aquatic animal health management and to assess environmental dissemination risks.
• Research and development: characterization of resistance mechanisms, plasmid-mediated transfer studies, evaluation of antibiotic alternatives such as probiotics and bacteriophages, and epidemiological investigations of resistance transmission between animals, humans, and the environment.

FAQ

What is the difference between MIC and disk diffusion testing?

Broth microdilution determines the minimum inhibitory concentration, the lowest antimicrobial concentration that visibly inhibits bacterial growth, providing a quantitative result suitable for breakpoint interpretation and resistance trend monitoring. Disk diffusion measures the diameter of the inhibition zone around an antimicrobial disk and yields a qualitative category of susceptible, intermediate, or resistant. Both methods are standardized and widely accepted; the choice depends on laboratory capacity, throughput, and the specific antimicrobial-bacterium combination.

How long does animal bacterial drug resistance testing take?

Phenotypic susceptibility testing generally requires 24 to 48 hours after isolation of a pure culture, with an additional 1 to 3 days for primary isolation and identification depending on the organism. Molecular PCR confirmation of specific resistance genes can be completed within one working day, while whole-genome sequencing with bioinformatic analysis typically requires 5 to 10 working days from culture submission.

Which breakpoints should be used for animal isolates?

Veterinary-specific breakpoints from CLSI VET01S should be applied whenever available, because they account for species-specific pharmacokinetics and pharmacodynamics of antimicrobials in animals. For zoonotic bacteria lacking veterinary breakpoints, human clinical breakpoints from CLSI M100 or EUCAST may be used, and this deviation should be clearly stated in the test report.

Can genomic testing replace phenotypic susceptibility testing?

Whole-genome sequencing comprehensively predicts resistance genotypes and is increasingly used for surveillance and outbreak investigation. However, phenotypic methods remain the reference for confirming actual resistance expression, detecting novel mechanisms, and establishing clinically actionable susceptibility categories. Current best practice combines both approaches, with phenotypic testing as the confirmatory backbone and genomics as a complementary epidemiological tool.

What sample volume and transport conditions are required?

Clinical samples should be collected aseptically in sterile containers, transported refrigerated at 2 to 8 degrees Celsius, and processed ideally within 24 hours of collection. Pure isolates should be submitted on agar slants or in transport medium with appropriate biosafety packaging. Accredited third-party laboratories provide detailed sampling guidelines to ensure the integrity and traceability of submitted specimens.